Robotisation of laboratory processes and further digitalisation have made genetic modification of organisms easier and more accessible for more and more organisations. As in the 1990s, we are experiencing a real biotechnology surge. Who would have thought that a vaccine could progress ‘from development to patient’ within 10 months?
This is what happened during the Covid pandemic! It was clearly an exceptional situation, but developments are moving faster and faster, which is a big improvement. The advantage is that the industry will help people who could not be helped before. New possibilities are emerging. This trend may in fact change the industry and ultimately improve the world.